DSA联合超声引导下治疗体表静脉畸形的临床观察

逯瑶; 张莉; 钱景瑜; 石傲; 葛玉瑶

doi:10.16766/j.cnki.issn.1674-4152.002356

DSA联合超声引导下治疗体表静脉畸形的临床观察

doi: 10.16766/j.cnki.issn.1674-4152.002356

逯瑶¹,
张莉^1, ,,
钱景瑜²,
石傲¹,
葛玉瑶¹

1.
蚌埠医学院第一附属医院整形外科，安徽蚌埠 233004
2.
蚌埠医学院第一附属医院介入科，安徽蚌埠 233004

基金项目:

安徽高校自然科学研究项目 KJ2021A0804

详细信息

通讯作者:
张莉，E-mail: drzhangli65@163.com

中图分类号: R543.6 R622.9
计量
- 文章访问数: 318
- HTML全文浏览量: 145
- PDF下载量: 4
- 被引次数: 0
出版历程
- 收稿日期: 2021-03-28
- 网络出版日期: 2022-08-13

Clinical observation of DSA combined with ultrasound-guided treatment of body superficial venous malformation

LU Yao¹,
ZHANG Li^{1
, ,},
QIAN Jing-yu²,
SHI Ao¹,
GE Yu-yao¹

1.
Department of Plastic Surgery, the First Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

摘要

摘要: 目的比较数字减影血管造影(DSA)联合超声引导下与单纯超声引导下治疗体表静脉畸形的有效性与安全性。方法回顾2012年1月—2020年12月蚌埠医学院第一附属医院整形科收治的30例体表静脉畸形患者，通过影像引导直接经皮穿刺注射硬化剂的治疗资料。根据超声和磁共振检查结果将病例分成A、B 2组，A组为空洞型病灶，周围无重要血管神经。B组为扩张型病灶，病灶较深或毗邻重要神经血管及骨骼。A组共19例，男性6例，女性13例，年龄为25(6，32)岁，选择单纯超声引导下进行治疗。B组11例，男性4例，女性7例，年龄为17(11，54)岁，采用DSA联合超声引导下治疗。治疗后随访3~12个月，比较2组的临床效果及术后不良反应情况。结果 A组19例，3例治愈，10例明显缓解，5例部分缓解，1例无效，总有效率为94.7%(18/19)，治愈率为15.79%(3/19)，每例平均注射2.40次；B组11例，6例治愈，2例明显缓解，3例部分缓解，0例无效，有效率为100.00%，治愈率为54.55%(6/11)，每例平均注射1.37次。主要不良反应为局部软组织肿胀疼痛，给予局部冰敷、改善微循环、静滴地塞米松等对症处理后，不适症状缓解。无肺栓塞或心脑血管意外等危及生命的严重并发症，未发现肉眼血尿或血红蛋白尿。结论在影像引导下, 应用聚桂醇联合平阳霉素治疗体静脉畸形，是一种安全有效的治疗方法。对于病灶最大直径>5 cm的畸形静脉，使用超声联合DSA引导下治疗，治愈率更高。
- 体表静脉畸形 /
- 数字减影血管造影 /
- 超声 /
- 聚桂醇 /
- 平阳霉素
Abstract: Objective To compare the efficacy and safety of digital subtraction angiography (DSA) combined with ultrasound-guided therapy in the treatment of superficial venous malformations. Methods Thirty cases of superficial venous malformation admitted to the Department of Orthopaedics of the First Affiliated Hospital of Bengbu Medical College from January 2012 to December 2020 were retrospectively treated with ultrasound-guided direct percutaneous puncture injection of sclerotherapy. According to the results of ultrasound and magnetic resonance examination, the patients were divided into group A and group B. Group A had cavitary lesion with no important peripheral blood vessels and nerves. In group B, the lesions were dilated, which were deeper or adjacent to important neurovascular and skeletal lesions. A total of 19 patients, including 6 males and 13 females, with an average age of 25 (6, 32) years, were enrolled in group A. In group B, 11 patients, including 4 males and 7 females, with an average age of 17 (11, 54) years, were treated with DSA combined with ultrasound guidance. After treatment, the patients were followed up for 3-12 months to compare the clinical effects and postoperative adverse reactions between group A and group B. Results In group A, 3 cases were cured, 10 cases had significant remission, 5 cases had partial remission, and 1 case was ineffective. The total effective rate was 94.7%(18/19), and the cure rate 15.79%(3/19). An average of 2.40 injections were given. In group B, 6 cases were cured, 2 cases had significant remission, 3 cases had partial remission, and 0 cases were ineffective. The effective rate was 100.00%, and the cure rate was 54.55%(6/11). Each patient was injected 1.37 times on average. The main adverse reactions were local soft tissue swelling and pain. After symptomatic treatment, such as local ice compress, improvement of microcirculation and intravenous dexamethasone, the symptoms were relieved. No serious complications such as pulmonary embolism or cardio-cerebrovascular accident were found, and no gross haematuria or haemoglobinuria was found. Conclusion Under imaging guidance, the application of lauromacrogol combined with pingyangmycin in the treatment of somatic venous malformations is a safe and effective method. For malformed veins with the largest diameter of the lesion >5 cm, DSA-guided treatment can result in higher cure rate.
- Superficial venous malformation /
- Digital subtraction angiography /
- Ultrasound /
- Lauromacrogol /
- Pingyangmycin

HTML全文

图 1 患者行超声引导下血管内硬化治疗对比

注：A为磁共振检查示右颈部皮下及肌间隙内肿物(箭头所指)，T₂抑脂像呈高信号；B为硬化术后2个月磁共振检查示右颈部皮下及肌间隙内T₂抑脂像高信号较前减弱(箭头所指)。

Figure 1. Comparison of patients undergoing ultrasound-guidedintravascular sclerotherapy

下载: 全尺寸图片幻灯片

图 2 患者行DSA联合超声引导下血管内硬化治疗前后对比

注：A为磁共振检查示右大腿皮下及肌间隙内肿物，T₂抑脂像呈高信号；B为硬化术后12个月磁共振检查示右大腿T₂抑脂像异常高信号消失；C为术中经皮穿刺静脉造影示畸形静脉团及引流静脉影；D为影像引导下注入硬化剂闭塞静脉团后，注入造影剂显示静脉团缩小。

Figure 2. Comparison of patients before and after DSA combinedwith ultrasound-guided endovascular sclerotherapy

下载: 全尺寸图片幻灯片

表 1 2组体表静脉畸形患者一般情况比较

Table 1. Comparison of general conditions of patients with superficialvenous malformation between the two groups

组别	例数	病灶分布部位(例)			年龄[M(P₂₅, P₇₅)，岁]	治疗次数 [M(P₂₅, P₇₅)，次]	随访时间 [M(P₂₅, P₇₅)，月]
组别	例数	头颈	四肢	躯干	年龄[M(P₂₅, P₇₅)，岁]	治疗次数 [M(P₂₅, P₇₅)，次]	随访时间 [M(P₂₅, P₇₅)，月]
A组	19	4	13	2	25(6, 32)	2(2, 3)	4(2, 9)
B组	11	4	7	0	17(11, 54)	1(1, 2)	5(3, 12)
统计量		1.794^a			0.240^b	-1.262^b	-0.449^b
P值		0.408			0.810	0.207	0.653
注：^a为χ²值，^b为Z值。

下载: 导出CSV

参考文献(20)

[1]	王亮, 吴长华, 宋丹, 等. 聚多卡醇泡沫硬化剂联合平阳霉素在学龄前儿童舌静脉畸形治疗中的应用[J]. 组织工程与重建外科杂志, 2020, 16(3): 182-185. doi: 10.3969/j.issn.1673-0364.2020.03.002 WANG L, WU C H, SONG D, et al. Sclerotherapy using polidocanol injectable foam combined with pinyangmycin in the treatment of venous malformation in tongue of preschoolers[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2020, 16(3): 182-185. doi: 10.3969/j.issn.1673-0364.2020.03.002
[2]	杨琴, 李学拥, 蒋立, 等. 超声引导下腔内注射治疗体表静脉畸形的临床疗效分析[J]. 中国美容整形外科杂志, 2017, 28(5): 283-286. doi: 10.3969/j.issn.1673-7040.2017.05.009 YANG Q, LI X Y, JIANG L, et al. Ultrasound-guided intralesional injection treatment of venous malformation[J]. Chinese Journal of Aesthetic and Plastic Surgery, 2017, 28(5): 283-286. doi: 10.3969/j.issn.1673-7040.2017.05.009
[3]	宋丹, 郭磊, 李静, 等. DSA导引下经皮硬化治疗儿童阴茎区静脉畸形的效果和安全性[J]. 介入放射学杂志, 2021, 30(1): 18-21. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS202101005.htm SONG D, GUO L, LI J, et al. DSA-guided percutaneous sclerotherapy for venous malformations at penile area in children: Clinical effect and safety[J]. Journal of Interventional Radiology, 201, 30(1): 18-21. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS202101005.htm
[4]	YAMAKI T, SASAKI Y, HASEGAWA Y, et al. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5): 707-714. doi: 10.1016/j.jvsv.2017.03.017
[5]	ACHAUER B M, CHANG C J, VANDER KAM V M. Management of hemangioma of infancy: Review of 245 patients[J]. Plast Reconstr Surg, 1997, 99(5): 1301-1308. doi: 10.1097/00006534-199705000-00014
[6]	中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019, 15(5): 277-317. doi: 10.3969/j.issn.1673-0364.2019.05.001 Chinese Society of Plastic Surgery Hemangioma and Vascular malformation Group. CSSVA Guidelines for Vascular Anomalies 2019[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2019, 15(5): 277-317. doi: 10.3969/j.issn.1673-0364.2019.05.001
[7]	李丽, 张斌, 尉莉, 等. 血管瘤与脉管畸形诊疗现状与展望[J]. 中华皮肤科杂志, 2020, 53(7): 501-507. LI L, ZHANG B, WEI L, et al. Diagnosis and treatment of hemangiomas and vascular malformations: Current status and prospect[J]. Chinese Journal of Dermatology, 2020, 53(7): 501-507.
[8]	SERONT E, VIKKULA M, BOON L M. Venous malformations of the head and neck[J]. Otolaryngol Clin North Am, 2018, 51(1): 173-184. doi: 10.1016/j.otc.2017.09.003
[9]	龚鑫沁, 梁杰. 静脉畸形的影像学诊断与治疗研究新进展[J]. 中国医疗美容, 2021, 11(2): 109-112. https://www.cnki.com.cn/Article/CJFDTOTAL-YLMR202102029.htm GONG X Q, LIANG J. Progress of imaging diagnosis and treatment for venous malformations[J]. China Medical Cosmetology, 2021, 11(2): 109-112. https://www.cnki.com.cn/Article/CJFDTOTAL-YLMR202102029.htm
[10]	KUMAR S, BHAVANA K, KUMAR B, et al. Image guided sclerotherapy of masseteric venous malformations[J]. Ann Otol Rhinol Laryngol, 2020, 129(6): 548-555. doi: 10.1177/0003489419898726
[11]	HAGE A N, CHICK J F B, SRINIVASA R N, et al. Treatment of venous malformations: The data, where we are, and how it is done[J]. Tech Vasc Interv Radiol, 2018, 21(2): 45-54. doi: 10.1053/j.tvir.2018.03.001
[12]	李嘉朋, 廖贵清, 陈巨峰, 等. DSA介导无水乙醇结合聚桂醇治疗头颈部高回流型静脉畸形[C]//中华口腔医学会口腔颌面-头颈肿瘤专业委员会. 2020年全国口腔颌面-头颈肿瘤学术大会暨中华口腔医学会口腔颌面-头颈肿瘤专业委员会学术年会——创新超越、共赢未来论文汇编, 武汉, 2020: 1. LI J B, LIAO G Q, CHEN J F, et al. Dsa-mediated anhydrous ethanol combined with macrogol in the treatment of head and neck venous malformations with high reflux[C]//Oral maxillofacial-Head and Neck Tumor Professional Committee of The Chinese Stomatological Association. 2020 National Oral Maxillofacial-Head and Neck Tumor Academic Conference of the Chinese Stomatological Association Oral Maxillofacial-Head and Neck Tumor Professional Committee academic Conference of the Chinese Stomatological Association: Innovative transcendence, win-win future paper collection. Wuhan, 2020: 1.
[13]	DING A, GONG X, LI J, et al. Role of ultrasound in diagnosis and differential diagnosis of deep infantile hemangioma and venous malformation[J]. J Vasc Surg Venous Lymphat Disord, 2019, 7(5): 715-723. doi: 10.1016/j.jvsv.2019.01.065
[14]	HUF V I, WOHLGEMUTH W A, ULLER W, et al. Contrast-enhanced ultrasound with perfusion analysis in patients with venous malformations before and after percutaneous treatment with ethanol-gel[J]. Clin Hemorheol Microcirc, 2020, 76(2): 161-170. doi: 10.3233/CH-209215
[15]	LEGIEHN G M. Sclerotherapy with Adjunctive Stasis of Efflux (STASE) in venous malformations: Techniques and strategies[J]. Tech Vasc Interv Radiol, 2019, 22(4): 100630. doi: 10.1016/j.tvir.2019.100630
[16]	SONG D, GUO L, SHENG H, et al. DSA-guided percutaneous sclerotherapy for children with oropharyngeal low-flow venous malformation[J]. Exp Ther Med, 2020, 19(5): 3405-3410.
[17]	ULLER W, EL-SOBKY S, ALOMARI A I, et al. Preoperative embolization of venous malformations using n-Butyl cyanoacrylate[J]. Vasc Endovascular Surg, 2018, 52(4): 269-274. doi: 10.1177/1538574418762192
[18]	左松, 董长宪, 肖莉, 等. 聚多卡醇泡沫硬化治疗儿童Puig's Ⅰ型和Ⅱ型肛周静脉畸形临床研究[J]. 中华介入放射学电子杂志, 2021, 9(1): 41-44. ZUO S, DONG C X, XIAO L, et al. Clinical study on sclerotherapy with polidocanol injectable foam in treatment of Puig's Ⅰ and Ⅱ perianal venous malformations in children[J]. Chinese Journal of Interventional Radiology (Eelectronic Edition), 2021, 9(1): 41-44.
[19]	BRILL R, DEISTUNG A, GUSSEW A, et al. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations[J]. J Vasc Surg Venous Lymphat Disord, 2020, 8(6): 1083-1089.
[20]	AHMAD S, AKHTAR F K. Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series[J]. Phlebology, 2019, 34(5): 355-361. https://pubmed.ncbi.nlm.nih.gov/30336759/